Tekla Life Sciences Investors (HQL) — Strategic Asset Allocation Index
Tekla Life Sciences Investors (HQL) has a Strategic Asset Allocation Index of 100.1% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $514.12 Million) total $514.12 Million, measured against net assets of $513.66 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Tekla Life Sciences Investors Strategic Asset Allocation Index (2006–2025)
This chart shows how Tekla Life Sciences Investors's Strategic Asset Allocation Index has evolved across 15 annual periods from 2006 to 2025. As of September 2025, the index stands at 100.1%, representing strategic assets of $514.12 Million against net assets of $513.66 Million USD. Explore Tekla Life Sciences Investors (HQL) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Tekla Life Sciences Investors (2006–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Tekla Life Sciences Investors from 2006 to 2025, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Tekla Life Sciences Investors (HQL) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.1% | $514.12 Million | $- | $514.12 Million | $513.66 Million | ▼ 0.0 pp |
| 2024 | 100.1% | $460.30 Million | $- | $460.30 Million | $459.69 Million | ▲ +1.2 pp |
| 2023 | 98.9% | $397.53 Million | $- | $397.53 Million | $401.93 Million | ▼ -5.2 pp |
| 2022 | 104.1% | $414.08 Million | $- | $414.08 Million | $397.90 Million | ▲ +2.0 pp |
| 2021 | 102.0% | $534.01 Million | $- | $534.01 Million | $523.44 Million | ▲ +1.9 pp |
| 2020 | 100.1% | $483.97 Million | $- | $483.97 Million | $483.57 Million | ▲ +0.8 pp |
| 2019 | 99.3% | $381.47 Million | $- | $381.47 Million | $384.16 Million | ▲ +1.2 pp |
| 2018 | 98.1% | $466.45 Million | $- | $466.45 Million | $475.49 Million | ▼ -2.0 pp |
| 2017 | 100.1% | $466.98 Million | $- | $466.98 Million | $466.35 Million | ▲ +10.8 pp |
| 2016 | 89.4% | $370.84 Million | $- | $370.84 Million | $414.97 Million | ▼ -6.5 pp |
| 2015 | 95.9% | $443.83 Million | $- | $443.83 Million | $462.84 Million | ▼ -3.2 pp |
| 2014 | 99.1% | $440.09 Million | $- | $440.09 Million | $444.09 Million | ▼ -0.9 pp |
| 2008 | 100.0% | $277.89 Million | $- | $277.89 Million | $277.80 Million | ▼ -0.2 pp |
| 2007 | 100.3% | $308.77 Million | $- | $308.77 Million | $308.00 Million | ▼ -0.2 pp |
| 2006 | 100.5% | $269.39 Million | $- | $269.39 Million | $268.10 Million | — |